MEDINCELL Trademark

Trademark Overview

On Friday, April 26, 2019, a trademark application was filed for MEDINCELL with the United States Patent and Trademark Office. The USPTO has given the MEDINCELL trademark a serial number of 88404466. The federal status of this trademark filing is REGISTERED as of Tuesday, June 16, 2020. This trademark is owned by MedinCell S.A.. The MEDINCELL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical preparations, namely, a drug delivery system comprising pharmaceutical compositions for subcutaneous or intraarticular administration for the continuous release of therapeutic agents for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, ...
medincell

General Information

Serial Number88404466
Word MarkMEDINCELL
Filing DateFriday, April 26, 2019
Status700 - REGISTERED
Status DateTuesday, June 16, 2020
Registration Number6077768
Registration DateTuesday, June 16, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Indication of Colors claimedThe color(s) black and blue is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word "MedinCell" in black letters with a blue design consisting of two horizontally oriented conjoined semi-circles located above the word "Cell" with a single vertically oriented semi-circle conjoined to the right of the two horizontally oriented conjoined semi-circles.
Goods and ServicesPharmaceutical preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical preparations, namely, a drug delivery system comprising pharmaceutical compositions for subcutaneous or intraarticular administration for the continuous release of therapeutic agents for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations and substances for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; veterinary preparations, namely, a drug delivery system comprising compositions that facilitate continuous release delivery of a wide variety of therapeutic subcutaneous or intraarticular veterinary agents; pharmaceutical compositions for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate controlled release delivery of subcutaneous or intraarticular active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of drug delivery compounds that facilitate sustained or extended release of the active ingredients for a wide variety of pharmaceuticals and veterinary pharmaceutical preparations; Drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical and veterinary pharmaceutical preparations; sustained or extended release drug delivery agents being compounds used to facilitate delivery of drugs, sold as an integral component of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; chemical preparations for medical or pharmaceutical use for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; Carriers and mediums being drug delivery agents comprised of compounds for facilitating the delivery of pharmaceutical and veterinary pharmaceutical preparations for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders; pharmaceutical and veterinary pharmaceutical preparations and substances for subcutaneous delivery for use in contraception, for the treatment of infectious, genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal and cognitive diseases and disorders, and for the treatment of substance abuse related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 14, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedinCell S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJacou 34830
FR
Party NameMedinCell S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJacou 34830
FR
Party NameMedinCell S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJacou 34830
FR

Trademark Events

Event DateEvent Description
Tuesday, June 16, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 27, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, February 7, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, January 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 31, 2020EXAMINER'S AMENDMENT ENTERED
Friday, January 31, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 31, 2020EXAMINERS AMENDMENT E-MAILED
Friday, January 31, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, January 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 10, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 10, 2019NON-FINAL ACTION E-MAILED
Wednesday, July 10, 2019NON-FINAL ACTION WRITTEN
Tuesday, July 9, 2019ASSIGNED TO EXAMINER
Wednesday, May 15, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, May 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 30, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

medincell treatment diseases disorders respiratory inflammatory neurological contraception preparations oncological cardiovascular